New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 4, 2014
08:03 EDTABBVAbbVie receives EMA and FDA orphan drug designation for ABT-414
AbbVie announced the European Medicines Agency and the FDA have granted orphan drug designation to AbbVie's investigational compound ABT-414, an anti-epidermal growth factor receptor antibody drug conjugate, which is being evaluated for safety and efficacy in patients with glioblastoma multiforme. G
News For ABBV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 5, 2015
06:34 EDTABBVAbbVie acquisition of Pharmacyclics a positive, says Deutsche Bank
Subscribe for More Information
05:59 EDTABBVJ&J says 'looking forward' to continuing collaboration with AbbVie
Johnson & Johnson (JNJ) issued a statement after AbbVie (ABBV) reached an agreement to acquire Pharmacyclics (PCYC) saying its "looking forward" to continuing its Imbruvica collaboration with AbbVie (ABBV), Bloomberg and Reuters reported. Pharmacyclics co-markets Imbruvica with Johnson & Johnson, and media reports as late as last night said J&J was close to buying its partner. AbbVie late last night announced it would acquire Pharmacyclics for $19.9B or $261.25 per share.
05:24 EDTABBVAbbVie up 1.2% after acquiring Pharmacyclics
Subscribe for More Information
05:24 EDTABBVPharmacyclics up 7.6% after being acquired by AbbVie
Subscribe for More Information
05:18 EDTABBVAbbVie to acquire Pharmacyclics for $261.25 per share, or $21B
Subscribe for More Information
05:17 EDTABBVAbbVie to acquire Pharmacyclics for $261.25 per share, or $21B
March 4, 2015
09:07 EDTABBVFDA making testosterone product makers change labeling
Subscribe for More Information
07:10 EDTABBVCowen to hold a conference
35th Annual Health Care Conference is being held in Boston on March 2-4 with webcasted company presentations to begin on March 4 at 8 am; not all company presentations may be webcasted. Webcast Link
March 3, 2015
11:46 EDTABBVLeerink biotech analyst holds an analyst/industry conference call
Subscribe for More Information
February 23, 2015
11:19 EDTABBVEnanta announces JAMA publication of AbbVie VIEKIRA PAK study results
Subscribe for More Information
11:04 EDTABBVAbbVie reports VIEKIRA PAK HPV/HIV co-infection study results published
Subscribe for More Information
February 20, 2015
10:33 EDTABBVBattleground update: AbbVie named top global pick at Jefferies
Subscribe for More Information
07:23 EDTABBVAbbVie replaces Pfizer as top global pharma pick at Jefferies
Subscribe for More Information
February 19, 2015
12:13 EDTABBVAbbVie increases quarterly dividend 4% to 51c per share
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use